338 related articles for article (PubMed ID: 21076401)
1. BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping.
Badie S; Escandell JM; Bouwman P; Carlos AR; Thanasoula M; Gallardo MM; Suram A; Jaco I; Benitez J; Herbig U; Blasco MA; Jonkers J; Tarsounas M
Nat Struct Mol Biol; 2010 Dec; 17(12):1461-9. PubMed ID: 21076401
[TBL] [Abstract][Full Text] [Related]
2. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
Kim TM; Son MY; Dodds S; Hu L; Hasty P
Mutat Res; 2014; 766-767():66-72. PubMed ID: 25847274
[TBL] [Abstract][Full Text] [Related]
3. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
Kim TM; Son MY; Dodds S; Hu L; Hasty P
Mutat Res; 2014; 766-767():66-72. PubMed ID: 25773776
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
Tacconi EM; Lai X; Folio C; Porru M; Zonderland G; Badie S; Michl J; Sechi I; Rogier M; Matía García V; Batra AS; Rueda OM; Bouwman P; Jonkers J; Ryan A; Reina-San-Martin B; Hui J; Tang N; Bruna A; Biroccio A; Tarsounas M
EMBO Mol Med; 2017 Oct; 9(10):1398-1414. PubMed ID: 28729482
[TBL] [Abstract][Full Text] [Related]
5. The breast cancer susceptibility gene BRCA2 is required for the maintenance of telomere homeostasis.
Min J; Choi ES; Hwang K; Kim J; Sampath S; Venkitaraman AR; Lee H
J Biol Chem; 2012 Feb; 287(7):5091-101. PubMed ID: 22187435
[TBL] [Abstract][Full Text] [Related]
6. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
8. Suppression of homologous recombination sensitizes human tumor cells to IGF-1R inhibition.
Lodhia KA; Gao S; Aleksic T; Esashi F; Macaulay VM
Int J Cancer; 2015 Jun; 136(12):2961-6. PubMed ID: 25388513
[TBL] [Abstract][Full Text] [Related]
9. Lamin A Δexon9 mutation leads to telomere and chromatin defects but not genomic instability.
Das A; Grotsky DA; Neumann MA; Kreienkamp R; Gonzalez-Suarez I; Redwood AB; Kennedy BK; Stewart CL; Gonzalo S
Nucleus; 2013; 4(5):410-9. PubMed ID: 24153156
[TBL] [Abstract][Full Text] [Related]
10. Brca2, Rad51 and Mre11: performing balancing acts on replication forks.
Costanzo V
DNA Repair (Amst); 2011 Oct; 10(10):1060-5. PubMed ID: 21900052
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.
Fridlich R; Annamalai D; Roy R; Bernheim G; Powell SN
DNA Repair (Amst); 2015 Jun; 30():11-20. PubMed ID: 25836596
[TBL] [Abstract][Full Text] [Related]
12. Visualization of direct and diffusion-assisted RAD51 nucleation by full-length human BRCA2 protein.
Belan O; Greenhough L; Kuhlen L; Anand R; Kaczmarczyk A; Gruszka DT; Yardimci H; Zhang X; Rueda DS; West SC; Boulton SJ
Mol Cell; 2023 Aug; 83(16):2925-2940.e8. PubMed ID: 37499663
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
Cousineau I; Abaji C; Belmaaza A
Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2.
Pefani DE; Latusek R; Pires I; Grawenda AM; Yee KS; Hamilton G; van der Weyden L; Esashi F; Hammond EM; O'Neill E
Nat Cell Biol; 2014 Oct; 16(10):962-71, 1-8. PubMed ID: 25218637
[TBL] [Abstract][Full Text] [Related]
15. The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry.
Ayoub N; Rajendra E; Su X; Jeyasekharan AD; Mahen R; Venkitaraman AR
Curr Biol; 2009 Jul; 19(13):1075-85. PubMed ID: 19540122
[TBL] [Abstract][Full Text] [Related]
16. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
[TBL] [Abstract][Full Text] [Related]
17. Structure and mechanism of action of the BRCA2 breast cancer tumor suppressor.
Shahid T; Soroka J; Kong E; Malivert L; McIlwraith MJ; Pape T; West SC; Zhang X
Nat Struct Mol Biol; 2014 Nov; 21(11):962-968. PubMed ID: 25282148
[TBL] [Abstract][Full Text] [Related]
18. Double-stranded DNA binding function of RAD51 in DNA protection and its regulation by BRCA2.
Halder S; Sanchez A; Ranjha L; Reginato G; Ceppi I; Acharya A; Anand R; Cejka P
Mol Cell; 2022 Oct; 82(19):3553-3565.e5. PubMed ID: 36070766
[TBL] [Abstract][Full Text] [Related]
19. RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks.
Dungrawala H; Bhat KP; Le Meur R; Chazin WJ; Ding X; Sharan SK; Wessel SR; Sathe AA; Zhao R; Cortez D
Mol Cell; 2017 Aug; 67(3):374-386.e5. PubMed ID: 28735897
[TBL] [Abstract][Full Text] [Related]
20. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.
Cousineau I; Belmaaza A
Mol Genet Genomics; 2011 Apr; 285(4):325-40. PubMed ID: 21409565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
